Fujifilm
Fujifilm, Helio Health Collaborate on Blood-Based Liver Cancer Test
Under the agreement, Helio Health's DNA methylation and biomarker-based blood test technology will be used with Fujifilm's μTASWako i30 immunoanalyzer.
Fujifilm Gets CE Mark for Point-of-Care Coronavirus Antigen Test
The silver amplification immunochromatography-based test is designed to detect SARS-CoV-2 antigens nasopharyngeal swab samples within 13 minutes.
In Brief This Week: Myriad Genetics, Illumina, Quest, and More
News items for in vitro diagnostics industry for the week of August 17, 2020.
Inspirata Inks Distribution Deal for Digital Pathology Software With Fujifilm
The deal gives Fujifilm global distribution rights to Inspirata's Dynamyx digital pathology workflow software with exclusivity in certain European markets.
Inspirata, Fujifilm Partner to Supply Digital Pathology Services to the UK National Health Service
The firms said that their respective technologies are complementary and bridge a technical gap between pathology, radiology, and oncology.